dr. davids on checkpoint blockade inhibition in hematologic malignancies after stem cell transplant
Published 6 years ago • 93 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
2:32
using checkpoint blockade inhibitors in relapsed hematologic malignancies after stem cell transplant
-
1:30
matthew davids, md, on how checkpoint inhibitors are being developed for hematologic malignancies
-
2:19
cd47-blocking agents: an emerging checkpoint inhibitor approach in hematologic malignancies
-
1:42
dr. gordon on the role of checkpoint inhibitors in hematologic malignancies
-
1:12
dr. van besien on autologous stem cell transplantation in hematologic malignancies
-
18:13
dr. daver on stem cell transplant considerations in hematologic malignancies in light of covid-19
-
2:22
does the use of the checkpoint inhibitor nivolumab affect the outcomes of transplant?
-
1:31
dr. matthew davids on advances in cll
-
8:25
can a stem cell transplant stop your ms?
-
41:53
stem cell transplant: patients reflect on their transplant journey
-
31:08
fantastic stem cells and where to find them with shiri gur-cohen
-
1:02
dr. damon on allogeneic stem cell transplant in aml
-
1:47
dr. shore on stem cell transplant in ethnic populations
-
16:10
stem cell transplant for myelofibrosis in the jak2 inhibitor era
-
1:22
dr. davids on updated data with ibrutinib/umbralisib in r/r cll and mcl
-
0:25
after donating stem cell or bone marrow, does the donor get weak or sick? dr. hasmukh balar
-
1:03
dr. mehta on stem cell transplant in multiple myeloma
-
58:20
secondary cancers after stem cell transplant
-
39:01
indications for allogeneic stem cell transplantation in aml
-
1:44
dr. perales on the progress ii trial in hematologic malignancies
-
0:45
dr. dandoy on tma risk after pediatric allogenic stem cell transplant
-
21:20
conditioning side effects in stem cell transplant by s. margossian | openpediatrics